Background: A 42-year-old woman with limited cutaneous systemic sclerosis presented with rapid-onset dyspnea on exertion, which had developed over the previous 8 weeks. She had not experienced any ...
ABNORMALITIES of respiratory function have been observed in scleroderma. 1–5 However, little attention has been paid to the study of the pulmonary function of patients with systemic lupus ...
Please provide your email address to receive an email when new articles are posted on . Evaluate the clinical symptomology and appropriate medical work-up for SSc to better identify patients in a ...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is characterized by chronic inflammation in both the pulmonary compartment and the rest of the ...
The randomized, double-blind, placebo-controlled, phase 3 SENSCIS trial enrolled 576 patients who were randomly assigned to twice-daily oral nintedanib 150 mg or placebo. The primary endpoint — annual ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced that the SENSCIS ® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVC a) in ...
Infants with cyanotic congenital heart disease palliated with placement of a systemic-to-pulmonary-artery shunt are at risk for shunt thrombosis and death. We investigated whether the addition of ...
Investigators used death certificate data to determine the annual average decline of deaths attributed to systemic sclerosis. Age-adjusted systemic sclerosis (SSc)—related mortality dropped by about 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback